Big Pharma fights patent disclosure demand from investors

Big Pharma fights patent disclosure demand from investors

Industry rejects call for transparency over use of strategy that can delay competition from generic medicines

Leave a Reply

Your email address will not be published. Required fields are marked *

WordPress Cookie Plugin by Real Cookie Banner